Riskpilot← Back to searchSign inGet full accessMedTec Partners International AB
ABActiveOrg 5593771255Mjölkviksvägen 4Business and other management consultancy activities · NACE 7020Est. 20220 employees
Revenue 2024
SEK 0
EBITDA margin
—
-190% vs 2023
Equity ratio
74.4%
Financial strength
Net profit 2024
SEK -34K
-217% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -32K | -190% |
| Net profit | SEK -34K | -217% |
| Total assets | SEK 774K | -22% |
| Equity | SEK 576K | -6% |
| Employees | 0 | — |
Legal name
MedTec Partners International AB
Org number
5593771255
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
25 april 2022
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna Styrelsen ska bestå av 3 styrelseledamöter och 0 styrelsesuppleanter.
Company purpose
Bolaget ska bedriva konsult- och investeringsverksamhet inom medicinteknik och life science-branschen samt därmed förenlig verksamhet.
Address
Mjölkviksvägen 4
Email
styrelse@medtecab.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 795 | 52 | 0 |
| Staff expenses | — | — | — |
| EBITDA | 669 | 35 | −32 |
| Depreciation & amort. | — | — | −0 |
| EBIT | 669 | 35 | −32 |
| Net financials | — | 1 | −3 |
| Profit before tax | 669 | 37 | −34 |
| Tax | −138 | −8 | −0 |
| Net profit | 531 | 29 | −34 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 938 | 991 | 774 |
| Equity | 581 | 611 | 576 |
| Long-term debt | — | — | 0 |
| Short-term debt | 231 | 221 | 93 |
| Total debt | 231 | 221 | 93 |
EBITDA margin
-3200000.0%
This company
15.8%
Market median
-20253265% vs market
20222024
Equity ratio
74.4%
This company
38.2%
Market median
+95% vs market
20222024
Return on equity
-5.9%
This company
18.4%
Market median
-132% vs market
20222024
Net profit margin
-3400000.0%
This company
8.1%
Market median
-41975409% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
BC Authorized Recipient of Service | Authorized Recipient of Service | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MedTec Partners International AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Barbara Carola Pötzsch | Authorized Recipient of Service | 0 companies |
| Martin Kiwit | Board of Directors | 0 companies |
| Gerald Olivier Rafael Pötzsch | Board of Directors | 0 companies |
| Heinrich Wilhelm Dalke | Chairman | 0 companies |